Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 9, 2006, Pages 3033-3038

  Azoulay Dupuis, E ^a,b   Mohler, J ^a   Bedos J P ^a   Barau, C ^a   Fantin, B ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Faculté Xavier Bichat   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CETHROMYCIN; ERYTHROMYCIN; KETOLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; IMMUNOCOMPETENCE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; ERYTHROMYCIN; KETOLIDES; MICE; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 33748697026     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00920-05     Document Type: Article

References (31)

1. Azoulay-Dupuis, E., E. Vallée, B. Veber, J. P. Bédos, J. Bauchet, and J. J. Pocidalo. 1992. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob. Agents Chemother. 36:2698-2703.
2. Azoulay-Dupuis, E., J. Mohler, and J. P. Bédos. 2004. Efficacy of BB-83698, a novel deformylase inhibitor, in a mouse model of pneumococcal pneumonia. Antimicrob. Agents Chemother. 48:80-85.
3. Bédos, J. P., E. Azoulay-Dupuis, E. Vallée, B. Veber, and J. J. Pocidalo. 1992. Individual efficacy of clarythromycin (A-56268) and its major human metabolite 14-hydroxy clarythromycin (A-62671) in experimental pneumococcal pneumonia in the mouse. J. Antimicrob. Chemother. 29:677-685.
4. Bodem, C. R., L. M. Lampton, D. P. Miller, E. F. Tarka, and E. D. Everett. 1983. Endobronchial pH: relevance to aminoglycoside activity in gram-negative bacillary pneumonia. Am. Rev. Respir. Dis. 127:39-41.
5. Brueggemann, A. B., G. V. Doern, H. K. Huynh, E. M. Wingert, and P. R. Rhomberg. 2000. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob. Agents Chemother. 44:447-449.
6. Bryskier, A., C. Agouridas, and J. F. Chantot. 1997. Ketolides: new semi-synthetic 14-membered-ring-macrolides, p. 39-50. In S. H. Zinner, L. S. young, J. F. Acar, and H. C. Neu (ed.), Expanding indications for the new macrolides, azalides, and streptogramins. Marcel Dekker, Inc., New York, N.Y.
7. Capobianco, J. O., Z. Cao, V. D. Shortridge, Z. Ma, R. K. Flamm, and P. Zhong. 2000. Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:1562-1567.
8. Davies, T. A., L. M. Ednie, D. M. Hoellman, G. A. Pankuch, M. R. Jacobs, and P. C. Appelbaum. 2000. Antipneumococcal activity of ABT-773 compared to those of 10 other agents. Antimicrob. Agents Chemother. 44:1894-1899.
9. Decousser, J.-W., P. Pina, F. Viguier, F. Picot, P. Courvalin, P. Allouch, et al. 2004. Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002. Antimicrob. Agents Chemother. 48:3636-3639.
10. Den Hollander, J. G., J. D. Knudsen, J. W. Mouton, K. Fuursted, N. Frimodt-Moller, H. A. Verbrugh, and F. Espersen. 1998. Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. Antimicrob. Agents Chemother. 42:377-382.
11. European Commission. 1986. Directive for the protection of vertebrate animals used for experimental and other scientific purposes (86/609/EEC). OFF. J. C. Eur. Commun. L. 358:1-29.
12. Fiese, E. F., and S. H. Steffen. 1990. Comparison of the acid stability of azithromycin and erythromycin A. J. Antimicrob. Chemother. 25(Suppl. A):39-47.
13. Hansen, L., H. Mauvais, and S. Douthwaite. 1999. The macrolide-ketolide antibiotic binding site is formed by structures in domain II and V of 23S rRNA. Mol. Microbiol. 31:623-631.
14. Hoban, D. J., A. K. Wierzbowski, K. Nichol, and G. Zhanel. 2001. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob. Agents Chemother. 45:2147-2150.
15. Jorgensen, J. H., S. A. Crawford, M. L. McElmeel, and C. G. Withney. 2004. Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48:605-607.
16. Kim, M. K., W. Zhou, P. R. Tessier, D. Xuan, M. Ye, C. H. Nightingale, and D. P. Nicolau. 2002. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. Antimicrob. Agents Chemother. 46:3185-3192.
17. Lieberman, D., F. Schlaeffer, H. Boldur, D. Lieberman, S. Horowitz, M. Leinonen, O. Horowitz, E. Manor, and A. Porath. 1996. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one-year prospective study of 346 consecutive patients. Thorax 51:179-184.
18. Low, D. L., J. de Azavedo, K. Weiss, T. Mazzulli, M. Kuhn, D. Church, K. Forward, G. Zhanel, and A. Simor. 2002. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob. Agents Chemother. 46:1295-1301.
19. Martin, J. R., P. Johnson, and M. F. Miller. 1985. Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin. Antimicrob. Agents Chemother. 27:314-319.
20. Mitten, M. J., J. Meulbroek, M. Nukkala, L. Paige, K. Jarvis, A. Oleksijew, A. Tovcimak, L. Hernandez, J. D. Alder, P. Ewing, Y. S. Or, Z. Ma, A. M. Nilius, K. Mollison, and R. K. Flamm. 2001. Efficacy of ABT-773, a new ketolide, against experimental bacterial infections. Antimicrob. Agents Chemother. 45:2585-2593.
21. Moine, P., J. B. Vercken, S. Chevret, C. Chastang, P. Gajdos, et al. 1994. Severe community-acquired pneumonia: etiology, epidemiology, and prognosis factors. Chest 105:1487-1495.
22. Morimoto, S., Y. Takahashi, Y. Watanabe, and S. Omura. 1984. Chemical modification of erythromycin. I. Synthesis and antibacterial activity of 6-O-methyl erythromycin A. J. Antibiot. 37:187-189.
23. National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial disk susceptibility tests. Approved standard, 7th ed. M2-A7, vol. 20. no. 1. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Neuhauser, M. M., J. L. Prause, L. H. Danziger, and S. L. Pendland. 2003. In vitro bactericidal activity of ABT-773 against ermB strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:1132-1134.
25. Niluis, A. M., D. M. Hensey-Rudloff, M. A. Reimann, and R. K. Flamm. 2002. Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens. J. Antimicrob. Chemother. 49:831-836.
26. Pallarés, R., J. Linarés, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martin, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
27. Schmitz, F.-J., S. Schwarz, D. Milatovic, J. Verhoef, and A. C. Fluit. 2002. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, and Moraxella catarrhalis. J. Antimicrob. Chemother. 50:145-148.
28. Shepard, M., and F. C. Faulkner. 1990. Pharmacokinetics of azithromycin in rats and dogs. J. Antimicrob. Chemother. 25(Suppl. A):49-60.
29. Shortridge, V. D., P. Zhong, Z. Cao, J. M. Beyer, L. S. Almer, N. C. Ramer, S. Z. Doktor, and R. K. Flamm. 2002. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci. Antimicrob. Agents Chemother. 46:783-786.
30. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585.
31. Weiss, K., C. Guibault, L. Cortes, C. Restieri, D. E. Low, et al. 2002. Genotypic characterisation of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin. J. Antimicrob. Chemother. 50:403-406.